Login / Signup

Oxazepam and cognitive reappraisal: A randomised experiment.

Gustav NilsonneSandra TammArmita GolkarAndreas OlssonKarolina SörmanKatarina HownerMarianne KristianssonMartin IngvarPredrag Petrovic
Published in: PloS one (2021)
While 25 mg oxazepam caused lower unpleasantness ratings in response to negative-valence images, we did not observe an effect of 25 mg oxazepam on cognitive reappraisal.
Keyphrases
  • clinical trial
  • deep learning
  • open label
  • convolutional neural network
  • double blind
  • study protocol
  • placebo controlled